Stock Update: Abbott Laboratories (NYSE:ABT) – New Abbott Technology May Uncover the Root of Critical Infections and Cut Health Care Costs

[PR Newswire] – WASHINGTON, Sept. 8, 2014 /PRNewswire/ — A new study suggests a pioneering testing technology could reduce hospital stays by up to eight days and lower annual health care costs for . . . → Read More: Stock Update: Abbott Laboratories (NYSE:ABT) – New Abbott Technology May Uncover the Root of Critical Infections and Cut Health Care Costs Similar Articles: Market Update (NYSE:ABT): Abbott to Showcase Innovations to Help Labs Solve Health Care Challenges at the American Association for Clinical Chemistry Lab Expo Company Update (NYSE:GE): Leading forensic laboratories participate in independent validation of the GE Healthcare Life Sciences and NetBio Rapid DNA system Abbott Laboratories (NYSE:ABT) – Abbott Announces FDA Approval of Its Supera® Stent to Treat People with Peripheral Artery Disease